Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses

Virology

Volumn 279, Issue 2, 2001, Pages 375-384

  García Sastre, Adolfo ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; CONFORMATIONAL TRANSITION; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOREGULATION; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RNA VIRUS; SHORT SURVEY; VIRUS INFECTION; VIRUS REPLICATION;

INFLUENZA A VIRUS; INFLUENZA VIRUS; INFLUENZAVIRUS A; RNA VIRUSES;

EID: 0035864298     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0756     Document Type: Article

References (129)

1. Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III
2. Viral mechanisms of immune evasion
3. Mx transgenic mice - Animal models of health
4. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA
5. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling
6. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection
7. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha
8. The Ebola virus VP35 protein functions as a type I interferon antagonist
9. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication
10. Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo
11. The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: Implications for translational regulation
12. Type I interferon gene expression: Differential expression of IFN-A genes induced by viruses and double-stranded RNA
13. Generation of bovine respiratory syncytial virus (BRSV) from cDNA, BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter
14. The herpes simplex virus US11 protein effectively compensates for the γ1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the α subunit of eukaryotic translation initiation factor 2
15. Viral inhibition of interferon signal transduction
16. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L
17. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase
18. JNK2 and IKKβ are required for activating the innate response to viral infection
19. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI
20. Respiratory syncytial virus
21. Genetic manipulation of non-segmented negative-strand RNA viruses
22. Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element
23. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2
24. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis
25. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays
26. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines
27. Sendai virus and simian virus 5 block activation of interferon-responsive genes: Importance for virus pathogenesis
28. The V protein of simian virus 5 inhibits interferon signaling by targeting STAT1 for proteasome-mediated degradation
29. Inhibition of the 2-5A synthetase activity by the NS1 protein of influenza A virus
30. Type I IFN modulates innate and specific antiviral immunity
31. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
32. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter
33. Rescue of influenza A virus from recombinant DNA
34. Oligo-2′,5′-adenylate synthetase activity in K562 cell lines persistently infected with measles or mumps virus
35. Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and vaccinia virus K3L is mediated by unique domains: Implications for kinase regulation
36. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation
37. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase
38. Translational control of viral gene expression in eukaryotes
39. The role of interferon in the tropism of influenza virus
40. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
41. Genetic manipulation of negative-strand RNA virus genomes
42. Sendai virus C proteins must interact directly with cellular components to interfere with interferon action
43. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state
44. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
45. Activation of NF-κ B by the dsRNA-dependent protein kinase PKR involves the IκB kinase complex
46. The interferon-induced protein kinase (PKR) triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors
47. Interferons: Cell signaling, immune modulation, antiviral response and virus countermeasures
48. Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-α/β-mediated responses
49. Cytokine-mediated control of viral infections
50. Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase
51. High virulence of attenuated Rift valley fever virus in mice lacking a functional type I interferon system
52. Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells
53. Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells
54. Binding of influenza A virus NS1 protein to dsRNA in vitro
55. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells
56. Influenza virus
57. The γ(1) 34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the α subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase
58. The Jak-STAT pathway
59. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 σ 3 protein
60. Virus interference. 1. The interferon
61. When two strands are better than one: The mediators and modulators of the cellular responses to double-stranded RNA
62. Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo
63. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3
64. Virus interception of cytokine-regulated pathways
65. Effect of deficiency of the double-stranded RNA-dependent protein kinase. PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes
66. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR
67. Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription
68. Unique functions of the NS1 protein
69. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF-1 and NF-κB
70. Paramyxoviridae: The viruses and their replication
71. Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR
72. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells
73. Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase
74. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene
75. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor
76. Direct suppression of Stat1 function during adenoviral infection
77. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor
78. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors
79. Interferon induction by viruses. XXI. Vesicular stomatitis virus: Interferon inducibility as a phylogenetic marker
80. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7
81. Adenovirus virus-associated RNA and translation control
82. The cellular inhibitor of the PKR protein kinase, P58(IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity
83. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
84. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway
85. Human cytomegalovirus inhibits IFN-α-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-α signal transduction
86. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV
87. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems
88. Evasion of host defenses by measles virus: Wild-type measles virus infection interferes with induction of alpha/beta interferon production
89. Generation of influenza A viruses entirely from cloned cDNAs
90. Viral strategies of immune evasion
91. The P58 cellular inhibitor complexes with the interferon-induced, double-stranded RNA-dependent protein kinase, PKR, to regulate its autophosphorylation and activity
92. An IκB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages
93. The application of transgenic and knockout mouse technology for the study of viral pathogenesis
94. Regulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways
95. Inhibition of nuclear factor κB activation by a virus-encoded IκB-like protein
96. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme
97. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity
98. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product
99. Antiviral properties of an attenuated influenza virus lacking the NS1 protein
100. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response
101. Development of the interferon system. I. In chicken cells development in ovo continues on time in vitro
102. Transient resistance of influenza virus to interferon action attributed to random multiple packaging and activity of NS genes
103. Novel functions of interferon-induced proteins
104. How cells respond to interferons
105. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity
106. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection
107. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein
108. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach
109. Double-stranded RNA-independent dimerization of interferon-induced protein kinase PKR and inhibition of dimerization by the cellular P581PK inhibitor
110. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase
111. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
112. Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein
113. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees
114. Interferons and other cytokines
115. The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses
116. Influenza A virus NS1 protein prevents the activation of NF-κB and induction of type I IFN
117. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo
118. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase
119. The Bunyamwera virus non-structural protein NSs is a repressor of the viral polymerase and confers interferon antagonistic function
120. The polyoma virus T antigen interferes with interferon-inducible gene expression
121. PKR; A sentinel kinase for cellular stress
122. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase
123. Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells
124. Replication-incompetent Sendai virus can suppress the antiviral action of type I interferon
125. Poor induction of interferon-induced 2′,5′-oligoadenylate synthetase (2-5 AS) in cells persistently infected with mumps virus is caused by decrease of STAT-1α
126. Characterization of the RNA associated with influenza A cytoplasmic inclusions and the interaction of NS1 protein with RNA
127. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response
128. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways
129. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription